Lexpos News

Following discussions between Community Pharmacy England, the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), several changes have been agreed within the July 2025 Drug Tariff associated with Advanced services and the Essential service, the Discharge Medicines Service (DMS). Changes to reflect the simplified DMS journey on MYS As [...]

The post Advanced and Essential service changes in the July Drug Tariff appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Depo-Medrone 80 mg in 2 mL (Maxearn Limited) Drug alert number: EL(25)A/29 Date issued: 25 June 2025 A batch of Depo-Medrone has been released to the market with an error. The vial over label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct [...]

The post MHRA Class 2 Medicines Recall: Depo-Medrone 80 mg in 2 mL (Maxearn Limited) appeared first on Community Pharmacy England.

Following the announcement of a new streamlined process for making claims for the Discharge Medicines Service (DMS), pharmacy owners are reminded of the actions they need to take ahead of this coming into effect on 6th July 2025. Claims Action Claims up to and including 30th June 2025 All DMS activity up until 30th June [...]

The post DMS: Have you claimed for completed activity? appeared first on Community Pharmacy England.

Today, the new application route for rearranging core opening hours came into force. This follows on from the laying of the relevant regulations in Parliament on 2 June, see our announcement. The new application route The new application route – which is available in addition to the pre-existing route – has a single regulatory test. [...]

The post New application route to rearrange core opening hours appeared first on Community Pharmacy England.

In response to a significant ongoing disruption to the supply of Venlafaxine 37.5mg modified-release tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 23rd June 2025, SSP083, provides that for every Venlafaxine 37.5mg modified-release tablet originally prescribed one Venlafaxine 37.5mg modified-release capsule must be supplied. SSP083, [...]

The post SSP for Venlafaxine 37.5mg modified-release tablets issued appeared first on Community Pharmacy England.